S-1286-116
Placed on Senate Legislative Calendar under General Orders. Calendar No. 178.
Sponsored by Martin Heinrich (D-NM)
What it does
This bill would require the Department of Energy (DOE) to create a funding program aimed at helping energy and related technologies move from DOE research facilities into the commercial marketplace. To qualify, a technology would need to have been developed at a DOE facility and show promising potential for commercial use. The bill does not specify a funding amount, leaving that to be determined through the appropriations process.
Who benefits
Private companies and startups seeking to license or commercialize technologies originally developed at DOE national laboratories (e.g., Argonne, Oak Ridge, Lawrence Berkeley). Entrepreneurs and investors in the energy sector who gain access to federally funded research. DOE national laboratory employees and researchers whose work may reach broader application. Consumers and industries that could eventually use commercially available technologies derived from federal research.
Who is hurt
Private energy companies that currently compete without the benefit of federally subsidized technology transfer, who may face new market competitors backed by public research funding. Taxpayers who fund the program if commercialized technologies do not generate sufficient public benefit or revenue returns. Other federal programs or priorities that could be displaced if discretionary funding is redirected to this program. Competing research institutions outside the DOE system that do not have access to the same commercialization pathway.
Supporters argue
Supporters argue that the federal government spends billions of dollars each year developing cutting-edge energy technologies at national laboratories, yet many of those innovations never reach the public because there is no structured pathway to bring them to market. This bill would create that pathway, ensuring taxpayers see a return on their research spending in the form of new products, industries, and jobs. By bridging the gap between laboratory discovery and commercial deployment — often called the "valley of death" in technology development — the program would accelerate the availability of advanced energy technologies, strengthen U.S. competitiveness in global energy markets, and reduce dependence on foreign technology. Supporters contend this is a targeted, practical measure that builds on existing DOE infrastructure rather than creating a new bureaucracy.
Opponents argue
Opponents argue that the federal government should not be in the business of picking which technologies succeed in the marketplace, as this distorts competition and may direct public funds toward technologies that the private sector has already evaluated and declined to pursue. They contend that if a technology has genuine commercial potential, private investors and companies have strong incentives to license and develop it without a government funding program. Critics also raise concerns about accountability: without a specified funding level or clear performance metrics in the bill's text, the program could grow without adequate congressional oversight. Additionally, opponents may argue that technology transfer decisions are better left to individual national laboratories and their existing partnership agreements rather than a new centralized DOE mandate.